RECITALSToll Manufacturing Agreement • December 31st, 1997 • Cmi Corp • Construction machinery & equip • Oklahoma
EX-10.36 12 d244198dex1036.htm TOLL MANUFACTURING AGREEMENT *** Text Omitted and Filed Separately Confidential Treatment Requested Under 17 C.F.R. §§ 200.80(b)(4) and 203.406 TOLL MANUFACTURING AGREEMENTToll Manufacturing Agreement • May 5th, 2020
THIS TOLL MANUFACTURING AGREEMENT (the “Agreement”), signed on September 30th, 2010, is made and entered into by and among Agro Industrie Recherches et Développements, S.A., a French entity (“ARD”), Bioamber, S.A.S., a French entity (“Bioamber”) and DNP Green Technology, Inc., a Delaware corporation (“DNP Green”).
EX-10.57 4 dex1057.htm RESTATED AND AMENDED TOLL MANUFACTURING AGREEMENT [ ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, IS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24B-2 OF THE...Toll Manufacturing Agreement • May 5th, 2020
This Restated and Amended And Restated Clinical and Commercial Supply Agreement (the “Agreement”) is entered into and made effective as of November 7, 2005 (the “Effective Date”) among, on the one hand, Gilead Sciences Limited., an Irish limited Company (“GSL”), whose registered address is Unit 13, Stillorgan Industrial Park, Blackrock, Co. Dublin, Ireland, and Gilead Sciences, Inc, a Delaware corporation (“GSI”) with its principal office located at 333 Lakeside Drive, Foster City, CA 94404, USA (Gilead World and Gilead Sciences collectively, “GILEAD”), and, on the other hand, Altana Pharma Oranienburg GmbH, a German corporation (“APO”) having its principal place of business at Lehnitzstrasse 70-98, 16515 Oranienburg, Germany. Gilead and APO are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
EX-10.11 6 filename6.htm A NON EXCLUSIVE TOLL MANUFACTURING AGREEMENTToll Manufacturing Agreement • May 5th, 2020 • Stockholm
This toll manufacturing agreement is made and entered into effective as of this 6th day of August 2013 (the “Effective Date”) by and between:
ContractToll Manufacturing Agreement • May 5th, 2020 • New York
EX-10.35 17 b86680a1exv10w35.htm EX-10.35 Exhibit 10.35 TOLL MANUFACTURING AGREEMENT TOLL MANUFACTURING AGREEMENT (the “Agreement”) effective as of the 18th day of May, 2009 (the “Effective Date”) between BioEnergy International, LLC, a Delaware limited liability company (“CUSTOMER”) and Fermic Sa de CV (“Fermic”). CUSTOMER and Fermic shall be separately referred to hereafter as a “Party” and collectively referred to as “Parties”. RECITALS CUSTOMER owns Patents (as defined below), patents pending and Know-How (as defined below) concerning microbial and biochemical processes by which a strain of microorganism was developed and is owned by CUSTOMER (the “Microorganism”). The Microorganism is grown and processed to yield certain amounts of succinic acid in a “broth-like” mixture, as further described on Schedule B (the “Fermentation Product”), which will be further processed using CUSTOMER’S Patents, patents pending and Know How to yield a purer succinic acid as further described on Sched
FIRST AMENDMENT TO THE TOLL MANUFACTURING AGREEMENT DATED SEPTEMBER 15, 2004 BETWEEN GENENTECH, INC. AND WYETHToll Manufacturing Agreement • February 17th, 2006 • Genentech Inc • Pharmaceutical preparations
This amendment (the “Amendment”), effective as of December 8, 2004, is made by and between Genentech, Inc., a Delaware corporation having a principal place of business at 1 DNA Way, South San Francisco, California 94080 (“Genentech”), and Wyeth, a Delaware corporation acting through its Wyeth Pharmaceuticals Division having its principal place of business at Five Giralda Farms, Madison, New Jersey 07940 (“Wyeth”). Wyeth and Genentech are referred to herein collectively as the “Parties.”
TOLL MANUFACTURING AGREEMENTToll Manufacturing Agreement • July 23rd, 2010 • China Kanghui Holdings
In the principle of equality, good faith and mutual benefit and upon consultation, Party A and Party B agree that Party B will manufacture for Party A dental implant parts and accessories surgical instruments for dental implant on the terms set forth below:
Confidential treatment requested on certain portions of this agreement. An unredacted version of this agreement has been filed separately with the Securities and Exchange Commission.Toll Manufacturing Agreement • August 5th, 2010 • Kinetic Concepts Inc • Miscellaneous furniture & fixtures
This Third Amendment (this “Amendment”) to the Toll Manufacturing Agreement, effective as of January 1, 2010 (the “Amendment Effective Date”), is made by and between KCI Manufacturing (“KCI”) and Avail Medical Products, Inc. (“Avail”). Avail and KCI are referred to herein as the “Parties.”
AMENDMENT NO. 5 TO THE TOLL MANUFACTURING AGREEMENTToll Manufacturing Agreement • March 15th, 2012 • Arena Pharmaceuticals Inc • Pharmaceutical preparations
This Amendment No. 5 (the “Amendment”), effective as of November 23, 2011, is by and between Arena Pharmaceuticals GmbH (“ARENA”) and Siegfried Ltd. (“SIEGFRIED”), and modifies the Toll Manufacturing Agreement, dated January 7, 2008, as amended, by and between ARENA and SIEGFRIED (the “Agreement”). All capitalized terms used herein and not otherwise defined shall have the meanings set forth in the Agreement.
BY AND BETWEEN SOLUTIA INC. ANDToll Manufacturing Agreement • November 9th, 2005 • Solutia Inc • Chemicals & allied products • Illinois
RESTATED TOLL MANUFACTURING AGREEMENTToll Manufacturing Agreement • February 15th, 2013 • BioAmber Inc. • Industrial organic chemicals
THIS RESTATED TOLL MANUFACTURING AGREEMENT (the “Agreement”), signed as of December 7, 2012 (the “Signature Date”), with an effective date as of December 1st, 2011 (the “Effective Date”), is made and entered into by and among Agro Industrie Recherches et Développements, S.A., a French entity (“ARD”), BioAmber S.A.S., a French entity (“BioAmber”) and BioAmber Inc., a Delaware corporation (“BioAmber US”).
ACT : INCOME TAX ACT, NO. 58 OF 1962 (the Act) SECTION : SECTION 9D(9)(b)(ii)(bb) SUBJECT : TOLL MANUFACTURING AGREEMENT AND THEToll Manufacturing Agreement • March 1st, 2012
HUBER ENTERS INTO AGREEMENT FOR FIRE RETARDANT PRODUCTS WITH ALMATISToll Manufacturing Agreement • December 16th, 2010
HEM will immediately be the sales and marketing contact for the products and assumes responsibility for technical support. The specific products to be produced include Hydral® 710, Hydral® PGA and SpaceRite® grades.
AMENDMENT TO TOLL MANUFACTURING AGREEMENTToll Manufacturing Agreement • August 5th, 2010 • Kinetic Concepts Inc • Miscellaneous furniture & fixtures
This Amendment (this “Amendment”) to the Toll Manufacturing Agreement, effective as of April 1st, 2009 (hereinafter referred to as the “Amendment Effective Date”), is made by and between KCI Manufacturing (hereinafter referred to as “KCI”) and Avail Medical Products, Inc.(hereinafter referred to as “Avail”). Avail and KCI are referred to herein collectively as the “Parties” and individually as “Party”.
Toll Manufacturing Agreement by and among Gilead World Markets, Ltd Queensgate House South Church Street PO Box 1234 GT Grand Cayman Cayman Islands Gilead Sciences, Inc. Foster City, CA 94404 USA and ALTANA Pharma Oranienburg GmbH Lehnitzstr. 70-98...Toll Manufacturing Agreement • March 11th, 2004 • Gilead Sciences Inc • Biological products, (no disgnostic substances)
This Amended And Restated Clinical and Commercial Supply Agreement (the “Agreement”) made and effective as of the 01 day of August, 2003 (the “Effective Date”) among, on the one hand, Gilead World Markets, Ltd., a Cayman Company (“Gilead World”), whose registered address is Queensgate House, South Church Street, P.O. Box 1234GT, Grand Cayman, Cayman Islands, and Gilead Sciences, Inc, a Delaware corporation (“Gilead Sciences”) with its principal office located at 333 Lakeside Drive, Foster City, CA 94404, USA (Gilead World and Gilead Sciences collectively, “GILEAD”), and, on the other hand, Altana Pharma Oranienburg GmbH, a German corporation (“APO”) having its principal place of business at Lehnitzstrasse 70-98, 16515 Oranienburg, Germany. Gilead and APO are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
AMENDMENT NO. 6 TO THE TOLL MANUFACTURING AGREEMENTToll Manufacturing Agreement • March 1st, 2013 • Arena Pharmaceuticals Inc • Pharmaceutical preparations
This Amendment No. 6 (the “Amendment”), effective as of August 20, 2012, is by and between Arena Pharmaceuticals GmbH (“ARENA”) and Siegfried Ltd. (“SIEGFRIED”), and modifies the Toll Manufacturing Agreement, dated January 7, 2008, as amended, by and between ARENA and SIEGFRIED (the “Agreement”). All capitalized terms used herein and not otherwise defined shall have the meanings set forth in the Agreement.
Confidential treatment requested on certain portions of this agreement. An unredacted version of this agreement has been filed separately with the Securities and Exchange Commission. FOURTH AMENDMENT TO TOLL MANUFACTURING AGREEMENTToll Manufacturing Agreement • March 1st, 2011 • Kinetic Concepts Inc • Miscellaneous furniture & fixtures
This Fourth Amendment (this “Amendment”) to the Toll Manufacturing Agreement, effective as of August 1, 2010 (the “Amendment Effective Date”), is made by and between KCI Manufacturing (“KCI”) and Avail Medical Products, Inc. (“Avail”). Avail and KCI are referred to herein as the “Parties.”
AMENDMENT NO. 4 TO THE TOLL MANUFACTURING AGREEMENTToll Manufacturing Agreement • August 9th, 2011 • Arena Pharmaceuticals Inc • Pharmaceutical preparations
This Amendment No. 4 (the “Amendment”), effective as of January 1, 2011, is by and between Arena Pharmaceuticals GmbH (“ARENA”) and Siegfried Ltd. (“SIEGFRIED”), and modifies the Toll Manufacturing Agreement, dated January 7, 2008, as amended, by and between ARENA and SIEGFRIED (the “Agreement”). All capitalized terms used herein and not otherwise defined shall have the meanings set forth in the Agreement.
TOLL MANUFACTURING AGREEMENT By and Between WYETH, Acting through its Wyeth Pharmaceuticals Division and GENENTECH, INC.Toll Manufacturing Agreement • November 4th, 2005 • Genentech Inc • Pharmaceutical preparations • Delaware
This TOLL MANUFACTURING AGREEMENT (the "Agreement") is made effective as of September 15, 2004 (the "Effective Date"), by and between Wyeth, a Delaware corporation acting through its Wyeth Pharmaceuticals Division having its principal place of business at Five Giralda Farms, Madison, New Jersey 07940 ("Wyeth"), and Genentech, Inc., a Delaware corporation, having its principal place of business at One DNA Way, South San Francisco, California 94080 ("Genentech"). Wyeth and Genentech may each be referred to herein individually as a "Party" and collectively as the "Parties."
TOLL MANUFACTURING AGREEMENTToll Manufacturing Agreement • March 5th, 2008 • Arena Pharmaceuticals Inc • Pharmaceutical preparations
WHEREAS, SIEGFRIED wishes to purchase from ARENA bulk tablets/capsules and packaged tablets/capsules for commercial sale by SIEGFRIED or SIEGFRIED’s partners.
TOLL MANUFACTURING AGREEMENTToll Manufacturing Agreement • September 7th, 2020
This Toll Manufacturing Agreement (this “Agreement”) is made as of the __________ (the “Effective Date”) by and between __________ ("Company), an individual located at __________, __________, __________ __________ and __________ ("Manufacturer"), an individual located at __________, __________, __________ __________.
RESTATED TOLL MANUFACTURING AGREEMENTToll Manufacturing Agreement • April 1st, 2013 • BioAmber Inc. • Industrial organic chemicals
THIS RESTATED TOLL MANUFACTURING AGREEMENT (the “Agreement”), signed as of December 7, 2012 (the “Signature Date”), with an effective date as of December 1st, 2011 (the “Effective Date”), is made and entered into by and among Agro Industrie Recherches et Développements, S.A., a French entity (“ARD”), BioAmber S.A.S., a French entity (“BioAmber”) and BioAmber Inc., a Delaware corporation (“BioAmber US”).
EXHIBIT 10.12 AMENDMENT TO TOLL MANUFACTURING AGREEMENT AGREEMENT dated as of this day of December, 1994 between PUREPAC PHARMACEUTICAL CO., a Delaware Corporation, having its principal office at 200 Elmora Avenue, Elizabeth, NJ 07207 ("Purepac"), and...Toll Manufacturing Agreement • September 29th, 1995 • Purepac Inc/ • Pharmaceutical preparations
Toll Manufacturing Agreement for the Production of Solar Modules Between SOLARFUN POWER HONG KONG LIMITED And Q-CELLS INTERNATIONAL GMBHToll Manufacturing Agreement • June 29th, 2010 • Solarfun Power Holdings Co., Ltd. • Semiconductors & related devices
* Confidential Treatment Requested. The redacted material has been separately filed with the Securities and Exchange Commission.
ContractToll Manufacturing Agreement • May 5th, 2020
<DOCUMENT> <TYPE>EX-10.2 <SEQUENCE>3 <FILENAME>ex10p2.txt <TEXT> <PAGE> Exhibit 10.2 TOLL MANUFACTURING AGREEMENT BY AND BETWEEN SOLUTIA INC. AND PHOSPHORUS DERIVATIVES INC. DATED NOVEMBER 4, 2005 <PAGE> <PAGE> TOLL MANUFACTURING AGREEMENT THIS TOLL MANUFACTURING AGREEMENT ("Agreement") made and entered into this 4th day of November, 2005 ("Commencement Date") by and between SOLUTIA INC. ("Manufacturer" or "Solutia"), a company organized and existing under the laws of the state of Delaware with principal offices located at 575 Maryville Centre Drive, St. Louis, MO 63141, and Phosphorus Derivatives Inc. ("Purchaser"), a corporation organized and existing under the laws of Delaware with principal offices located at 622 Emerson Road, Suite 500, St. Louis, MO 63141. RECITALS A. Solutia, ICL Performance Products Holding Inc. ("Buyer"), Israel Chemicals Limited, FMC Corporation and Astaris LLC have entered into an Asset Purchase Agreement ("APA") dated September 1, 2005 pursuant to which Buy
TOLL MANUFACTURING AGREEMENTToll Manufacturing Agreement • February 11th, 2005 • Amphastar Pharmaceuticals, Inc. • New Jersey
THIS AGREEMENT effective this 26 day of June, 2003 (hereinafter referred to as the "effective date") by and between Amphastar Pharmaceuticals, Inc., a corporation organized under the law of the State of California, having its principal office at 11570 Sixth St., Rancho Cucamonga, CA 91730 (hereinafter "AMPHASTAR"), and ORGANON USA INC., a corporation organized under that laws of New Jersey, having its principal office at 375 Mt. Pleasant Avenue, West Orange, New Jersey 07052 (hereinafter "ORGANON").
Toll Manufacturing Agreement for the Bulk Drug Substance of Actemra®, a Humanized Anti-Human IL-6 Receptor Monoclonal AntibodyToll Manufacturing Agreement • July 30th, 2008
July 31, 2008 (Tokyo) - Chugai Pharmaceutical Co., Ltd. [Head Office: Chuo-ku, Tokyo; President Osamu Nagayama (hereafter, “Chugai”)] announced today that on July 30 (Eastern Daylight Time), the company executed a toll manufacturing and supply agreement for the bulk drug substance of Actemra®, a humanized anti-human IL-6 receptor monoclonal antibody, with Genentech, Inc. [Head Office: California, USA; Chairman & CEO Arthur D. Levinson (hereafter, “Genentech”)], which is majority-owned by F. Hoffmann-La Roche Ltd. [Head Office: Basel, Switzerland; CEO: Severin Schwan (hereafter “Roche”)]. Genentech, as a toll manufacturer for Chugai, will manufacture Actemra® bulk drug substance following the completion of a manufacturing licensing transfer from Chugai. The Utsunomiya Plant of Chugai Pharma Manufacturing Co., Ltd., a wholly-owned subsidiary of Chugai, will also continue producing Actemra® bulk drug substance to its final formulation.
TOLL MANUFACTURING AGREEMENTToll Manufacturing Agreement • November 6th, 2020
☐ corporation ☐ limited liability company ☐ partnership ☐ limited partnership ☐ limited liability partnership located at ________________________________________ [Address] and
Toll Manufacturing Agreement PdfToll Manufacturing Agreement • February 5th, 2021
sAudpmeirsfsluivoeusQlyuiallnadn bsruubtjaolilny, hoiswpalosvhearkseinisteJrcearolamtees?kAiscsq-uoifrfasbuleppalenldy.uInf iclaroteurcahl eTdamorruenhaolulostetehdisRkurdeime luinssuasltloydsgtreipsuhiinsgletpeenrfsolsdk. eletonizes drily or begat
State of TOLL MANUFACTURING AGREEMENTToll Manufacturing Agreement • November 10th, 2020
AMENDMENT NO. 1 TO THE TOLL MANUFACTURING AGREEMENTToll Manufacturing Agreement • March 16th, 2009 • Arena Pharmaceuticals Inc • Pharmaceutical preparations
This Amendment No. 1 (the “Amendment”), effective December 18, 2008, is by and between Arena Pharmaceuticals GmbH (“Arena”) and Siegfried Ltd. (“Siegfried”), and modifies the Toll Manufacturing Agreement, dated January 7, 2008, by and between Arena and Siegfried (the “Agreement”). All capitalized terms used herein and not otherwise defined shall have the meanings set forth in the Agreement.
AMENDMENT NO. 2 TO THE TOLL MANUFACTURING AGREEMENTToll Manufacturing Agreement • March 16th, 2010 • Arena Pharmaceuticals Inc • Pharmaceutical preparations
This Amendment No. 2 (the “Amendment”), effective September 17, 2009, is by and between Arena Pharmaceuticals GmbH (“Arena”) and Siegfried Ltd. (“Siegfried”), and modifies the Toll Manufacturing Agreement, dated January 7, 2008, as amended, by and between Arena and Siegfried (the “Agreement”). All capitalized terms used herein and not otherwise defined shall have the meanings set forth in the Agreement.
TOLL MANUFACTURING AGREEMENTToll Manufacturing Agreement • March 16th, 2006 • Alpharma Inc • Pharmaceutical preparations • New Jersey
THIS TOLL MANUFACTURING AGREEMENT (the "Agreement") is made on 19th of December, 2005 ("Effective Date") between ALPHARMA BRANDED PRODUCTS DIVISION INC., a Delaware corporation ("Alpharma"), and PUREPAC PHARMACEUTICAL CO., a Delaware corporation ("Purepac"). Alpharma and Purepac are each individually a "Party" and are collectively the "Parties".
AVAIL MEDICAL PRODUCTS, INC. & KCI MANUFACTURING TOLL MANUFACTURING AGREEMENTToll Manufacturing Agreement • February 26th, 2008 • Kinetic Concepts Inc /Tx/ • Miscellaneous furniture & fixtures • Texas
This Toll Manufacturing Agreement (this "Agreement") is entered into as of December 14, 2007, by and between on the first part KCI Manufacturing, a company incorporated under the laws of Ireland, with an address of Athlone Business & Technology Park, Garrycastle, Athlone, Co. Westmeath, Ireland ("KCI Manufacturing") and on the second part Avail Medical Products, Inc., a Delaware corporation with principal offices at 1600 Wells Fargo Tower, 201 Main Street, Fort Worth, Texas 76102 (collectively "Avail"). This Agreement will be effective as of November 30, 2007 (the "Effective Date"). Either Avail or KCI Manufacturing may be referred to herein as a “Party” or collectively as the “Parties.”
AMENDMENT TO TOLL MANUFACTURING AGREEMENTToll Manufacturing Agreement • November 5th, 2008 • Kinetic Concepts Inc /Tx/ • Miscellaneous furniture & fixtures
This Amendment (this “Amendment”) to the Toll Manufacturing Agreement, dated as of July 31, 2008 (“Amendment Effective Date”), is made by and between KCI Manufacturing (“KCI”) and Avail Medical Products, Inc.(“Avail”). Avail and KCI are referred to herein as the “Parties”.
